Source:http://linkedlifedata.com/resource/pubmed/id/16105995
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2005-8-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1538-3598
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
17
|
pubmed:volume |
294
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
784-6
|
pubmed:dateRevised |
2006-11-7
|
pubmed:meshHeading |
pubmed-meshheading:16105995-Buprenorphine,
pubmed-meshheading:16105995-Family Practice,
pubmed-meshheading:16105995-Humans,
pubmed-meshheading:16105995-Narcotic Antagonists,
pubmed-meshheading:16105995-Opioid-Related Disorders,
pubmed-meshheading:16105995-Primary Health Care,
pubmed-meshheading:16105995-United States
|
pubmed:year |
2005
|
pubmed:articleTitle |
Office-based treatment for opioid addiction achieving goals.
|
pubmed:publicationType |
News
|